Page last updated: 2024-10-29

ketanserin and Gastric Fistula

ketanserin has been researched along with Gastric Fistula in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Gastric Fistula: Abnormal passage communicating with the STOMACH.

Research Excerpts

ExcerptRelevanceReference
" The dose-response kinetics with four doses of bethanechol with and without somatostatin showed inhibition of a non-competitive type for gastric acid secretion and of a competitive type for antral motility with regard to amplitude."1.27Effect of somatostatin on bethanechol-stimulated gastric acid secretion and gastric antral motility in dogs with gastric fistula. ( Andersen, D; Bech, K; Ladegaard, L, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bech, K1
Ladegaard, L1
Andersen, D1

Other Studies

1 other study available for ketanserin and Gastric Fistula

ArticleYear
Effect of somatostatin on bethanechol-stimulated gastric acid secretion and gastric antral motility in dogs with gastric fistula.
    Scandinavian journal of gastroenterology, 1985, Volume: 20, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Bethanechol Compounds; Dogs; Dom

1985